AI-generated summary
The authors describe a single nondiabetic woman who received transcutaneous photobiomodulation on the radial artery, applied either right after a standardized meal or at peak postprandial glucose, with interstitial glucose tracked every 5 minutes and compared with a no-intervention control period. The authors report that a single application at the wavelengths and doses tested did not affect interstitial glucose levels in this participant. Because the study involved only one subject, the findings cannot be generalized.
- Who or what was studied
- One nondiabetic woman with a significant family history of diabetes mellitus
- Limits stated in the abstract
- The study included only a single subject, used a single application, and measured interstitial rather than blood glucose.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.